Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Open in API
Filings indexed 7,016 across all filing types
Latest filing 2026-03-09 Board/Management Inform…
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Board Committee Change
Board/Management Information Classification · 100% confidence The document is a short announcement from GSK PLC regarding a change in the membership of its Board committee (specifically, the appointment of Elizabeth McKee Anderson to the Corporate Responsibility Committee). This falls directly under the definition of an announcement of changes in the company's board of directors or senior management.
2026-03-09 English
GSK and Alfasigma agree global linerixibat rights
M&A Activity Classification · 95% confidence The document is an official announcement from GSK plc regarding a licensing agreement with Alfasigma for the worldwide rights to the drug linerixibat. It details the financial terms of the transaction, including upfront payments and milestone payments. This type of corporate development, specifically involving the sale of assets or licensing rights, falls under M&A activity (mergers, acquisitions, and divestitures). Although it is distributed via RNS, the content is a substantive announcement of a business transaction rather than a generic regulatory filing or a report publication notice.
2026-03-09 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It provides specific details such as the number of shares purchased, price paid, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-03-09 English
Filing of GSK plc 2025 Annual Report on Form 20-F
Report Publication Announcement Classification · 100% confidence The document is a short announcement (3491 characters) from GSK plc notifying the market that it has filed its 2025 Annual Report on Form 20-F with the SEC. It provides links to the report and instructions for shareholders to request hard copies. Per the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself, and therefore qualifies as a Report Publication Announcement (RPA).
2026-03-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from GSK plc regarding the purchase of its own shares (share buyback) on the London Stock Exchange and other venues. It includes specific details such as the number of shares purchased, price paid, and the impact on treasury shares and total voting rights. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS).
2026-03-06 English
GSK publishes Annual Report 2025
Report Publication Announcement Classification · 95% confidence The document is an announcement from GSK plc dated 5 March 2026 regarding the publication of its Annual Report for the year ended 31 December 2025. The text states that the Annual Report 2025 has been published on the company's website and submitted to the FCA's National Storage Mechanism. It explicitly mentions that this announcement is not a substitute for reading the Annual Report in full, indicating that the actual report is not included in this document. The document length is only 2999 characters, which is quite short and consistent with an announcement rather than the full report. According to the 'MENU VS MEAL' rule, such a short document announcing the publication of a report should be classified as a Report Publication Announcement (RPA), not as the Annual Report (10-K). Therefore, the correct classification is RPA with high confidence.
2026-03-05 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.